Your browser doesn't support javascript.
loading
Denosumab or oral bisphosphonates in primary osteoporosis: a "real-life" study.
Cairoli, E; Palmieri, S; Goggi, G; Roggero, L; Arosio, M; Chiodini, I; Eller-Vainicher, C.
Afiliação
  • Cairoli E; Unit of Endocrinology, Fondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico, Padiglione Granelli, Via Francesco Sforza 35, 20122, Milan, Italy.
  • Palmieri S; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
  • Goggi G; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
  • Roggero L; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
  • Arosio M; Unit of Endocrinology, Fondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico, Padiglione Granelli, Via Francesco Sforza 35, 20122, Milan, Italy.
  • Chiodini I; Unit of Endocrinology, Fondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico, Padiglione Granelli, Via Francesco Sforza 35, 20122, Milan, Italy.
  • Eller-Vainicher C; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
J Endocrinol Invest ; 41(8): 1005-1013, 2018 Aug.
Article em En | MEDLINE | ID: mdl-29340971

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose Pós-Menopausa / Difosfonatos / Conservadores da Densidade Óssea / Denosumab Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Endocrinol Invest Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose Pós-Menopausa / Difosfonatos / Conservadores da Densidade Óssea / Denosumab Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Endocrinol Invest Ano de publicação: 2018 Tipo de documento: Article